| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $52.1M | +57.7% |
| R&D Expense | $420.0M | +82.8% |
| SG&A Expense | $90.3M | +27.0% |
| Operating Income | -$458.2M | -71.1% |
| Net Income | -$474.2M | -77.0% |
| EPS (Basic) | -$6.16 | -63.0% |
| EPS (Diluted) | -$6.16 | -63.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $523.5M | +324.2% |
| Short-term Investments | $669.1M | +7.0% |
| Accounts Receivable | $3.8M | +85.5% |
| Current Assets | $1.22B | +58.2% |
| Total Assets | $1.52B | +17.4% |
| Current Liabilities | $126.6M | +0.6% |
| Stockholders' Equity | $1.24B | +18.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$333.3M | -48.1% |
| Capital Expenditures | $13.6M | +6.3% |
| Investing Cash Flow | $160.3M | +129.1% |
| Financing Cash Flow | $583.0M | -20.9% |
| Free Cash Flow | -$346.8M | -45.9% |